EAGLE ASSET MANAGEMENT INC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$21,340,000
-15.4%
433,834
+16.0%
0.10%
-33.1%
Q4 2020$25,211,000
+19.9%
373,875
-15.9%
0.14%
+31.5%
Q3 2020$21,024,000
-4.3%
444,778
+2.5%
0.11%
-13.6%
Q2 2020$21,974,000
+145.4%
433,935
+116.2%
0.12%
+123.2%
Q1 2020$8,954,000
+114.3%
200,723
+130.7%
0.06%
+180.0%
Q4 2019$4,179,00087,0110.02%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
AXON CAPITAL LP 216,200$9,729,00020.31%
GREAT POINT PARTNERS LLC 1,974,385$88,847,000,0009.86%
RTW INVESTMENTS, LP 3,137,361$141,181,0007.54%
Asymmetry Capital Management, L.P. 280,542$12,624,0006.84%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 259,000$11,642,0004.32%
Boxer Capital, LLC 1,000,000$45,000,0003.87%
Opaleye Management Inc. 226,388$10,187,0003.10%
SECTORAL ASSET MANAGEMENT INC 450,638$20,279,0002.42%
SCOPIA CAPITAL MANAGEMENT LP 983,005$44,235,0001.96%
Chubb Ltd 8,180$368,0001.82%
View complete list of PTC THERAPEUTICS INC shareholders